1. Advancing women’s health through formulary coverage innovations
Care gaps in women’s health are closing, thanks to increased cultural awareness of gendered healthcare disparities, according to Susan Cantrell, CEO of the Academy of Managed Care Pharmacy.
2. The global impact of underfunding women’s health
Bias and stigma are to blame for the way women’s health research has fallen behind, according to Monica Christmas, M.D., director of UChicago Medicine’s menopause program and the Center for Women’s Integrated Health and Valentina Sartori, Ph.D., a partner in McKinsey & Company’s Life Sciences Practice and affiliated leader of the McKinsey Health Institute.
3. FDA panel challenges hormone replacement therapy risks
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said there were more risks than benefits for menopausal women taking hormone therapy.
4. The long-term cost of major menopause misconceptions
An overview of menopause taboo, the lingering effects of the Women’s Health Initiative study and what employers can do to support their menopausal workers, according to Stephanie Faubion, M.D., director of the Mayo Clinic’s Center for Women’s Health and medical director of The Menopause Society.
5. FDA approves first at-home cervical cancer screening device
Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
